ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,157Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 761

$667K Total Retail Price of All Prescriptions

Rank: 51 out of 761

535 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 535 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 535 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 10,382 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 553 530 1 3
SIMVASTATIN 444 407 2 2
AMLODIPINE BESYLATE 407 393 3 6
OMEPRAZOLE 365 343 4 4
WARFARIN SODIUM 363 358 5 9
LISINOPRIL 279 256 6 1
PREDNISONE 275 262 7 30
FUROSEMIDE 267 265 8 7
HYDROCODONE-ACETAMINOPHEN 253 183 S3 9 5
ATENOLOL 209 205 10 8
SPIRONOLACTONE 195 194 11 45
CRESTOR 188 172 12 36
GLIMEPIRIDE 185 176 13 48
ATORVASTATIN CALCIUM 179 168 14 12
CITALOPRAM HBR 169 158 15 19
METFORMIN HCL 167 162 16 10
METOPROLOL SUCCINATE 166 158 17 16
DIOVAN 165 142 18 58
FENOFIBRATE 154 145 19 91
GABAPENTIN 138 127 20 15
POTASSIUM CHLORIDE 131 128 21 18
METOPROLOL TARTRATE 124 122 22 14
LOSARTAN POTASSIUM 124 123 22 13
ALLOPURINOL 123 121 24 28
PRAVASTATIN SODIUM 120 116 25 20
ZETIA 120 116 25 87
ZOLPIDEM TARTRATE 115 100 27 22
TRAZODONE HCL 114 97 28 23
SYNTHROID 113 105 29 64
TRIAMTERENE-HCTZ 106 99 30 42
DONEPEZIL HCL 105 105 31 33
SERTRALINE HCL 102 95 32 25
CYMBALTA 100 88 33 53
HYDROCHLOROTHIAZIDE 94 88 34 11
CARVEDILOL 87 87 35 26
DIGOXIN 80 80 36 43
ALENDRONATE SODIUM 80 79 36 21
NAMENDA 78 78 38 59
VYTORIN 73 66 39 168
LOVASTATIN 70 69 40 17
LANTUS 70 50 40 41
ADVAIR DISKUS 67 67 42 37
CIPROFLOXACIN HCL 64 64 43 63
SPIRIVA 62 62 44 56
MIRTAZAPINE 61 56 45 50
VERAPAMIL ER 61 51 45 109
NORTRIPTYLINE HCL 59 44 47 101
TAMSULOSIN HCL 58 56 48 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 57 49 35
PREMARIN 57 55 R 49 88
ESTRADIOL 56 45 R 51 80
AZITHROMYCIN 53 49 52 70
AMITRIPTYLINE HCL 52 42 R 53 54
DOXAZOSIN MESYLATE 51 41 54 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.